Chemours (CC) reported $5.8B in revenue for fiscal 2025, +0.4% year on year. That ranks #740 by revenue among 2853 SEC filers and #56 in Materials. It posted a net loss of −$386M for the same year. Revenue has declined 0.9% a year on average since 2014 ($6.4B then). The fiscal 2025 balance sheet shows $7.4B in total assets, $670M in cash and $4.1B in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $5.8B | +0.4% | FY20252025-12-31 |
| Gross profitGrossProfit | $902M | −21.0% | FY20252025-12-31 |
| Operating incomeIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | −$277M | −$383M | FY20252025-12-31 |
| Net incomeNetIncomeLoss | −$386M | −$455M | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $264M | +$897M | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $213M | −40.8% | FY20252025-12-31 |
| Total assetsAssets | $7.4B | −1.7% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $250M | −56.2% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $670M | −6.0% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $4.1B | +1.0% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $1.4B | −$29.0M | Open → |
| Q2 20262026-06-30 | $1.6B | −$274M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 119 of 134 companies compared | −6.6% | |
| Operating marginRank 117 of 131 companies compared | −4.8% | |
| R&D as share of revenueRank 22 of 75 companies compared | 1.9% | |
| Cash as share of revenueRank 53 of 132 companies compared | 11.5% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Chemours Co
- Ticker
- CC
- Exchange
- NYSE
- SIC classification
- Chemicals & Allied Products (2800)
- Fiscal year end
- 12-31
- CIK
- 0001627223
Filings
- 10-QAug 5, 2026Open filing →
- 10-QMay 5, 2026Open filing →
- 10-KFeb 24, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| OlinOLN | $6.8B | −$101M |
| O-I GlassOI | $6.4B | −$129M |
| Martin Marietta MaterialsMLM | $6.2B | $1.1B |
| ChemoursCC | $5.8B | −$386M |
| HuntsmanHUN | $5.7B | −$284M |
| AlbemarleALB | $5.1B | −$511M |
| Axalta Coating SystemsAXTA | $5.1B | $379M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Chemours — Key figures |url=https://companiesranked.com/en/company/chemours |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Chemours — Key figures. CompaniesRanked. https://companiesranked.com/en/company/chemoursBibTeX
@misc{companiesranked-en-company-chemours-2026,
author = {{CompaniesRanked}},
title = {{Chemours — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/chemours}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001193125-26-065201 · February 24, 2026
{{cite web |title=Chemours — Key figures — 10-K (0001193125-26-065201) |url=https://www.sec.gov/Archives/edgar/data/1627223/000119312526065201/cc-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.